PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Biomedical Informatics Program, University of California San Diego, La Jolla, CA, United States of America.\', \'Division of Medical Genetics, Department of Medicine, University of California San Diego, La Jolla, CA, United States of America.\', \'The Laboratory of Immunology, Department of Medicine, University of California San Diego, La Jolla, CA, United States of America.\', \'Moores Cancer Center, University of California San Diego, La Jolla, CA, United States of America.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1371/journal.pone.0246731
?:doi
?:hasPublicationType
?:journal
  • PloS one
is ?:pmid of
?:pmid
?:pmid
  • 33571241
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.164
?:rankingScore_hIndex
  • 241
is ?:relation_isRelatedTo_publication of
?:title
  • In silico analysis suggests less effective MHC-II presentation of SARS-CoV-2 RBM peptides: Implication for neutralizing antibody responses.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33571241>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33571241>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all